Use of an aldosterone antagonist after myocardial infarction has improved outcomes in patients with heart failure with reduced ejection fraction, but whether it benefits others remains unclear.

Myocardial infarction (MI) is an uncommonly suspected cause of morbidity in children. This retrospective case series study was undertaken to ascertain the incidence and etiologies of MI in the ...